Imatinib improves but may not fully reverse the poor prognosis of patients with CML with derivative chromosome 9 deletions.
Huntly BJ, Guilhot F, Reid AG, Vassiliou G, Hennig E, Franke C, Byrne J, Brizard A, Niederwieser D, Freeman-Edward J, Cuthbert G, Bown N, Clark RE, Nacheva EP, Green AR, Deininger MW.
Huntly BJ, et al. Among authors: green ar.
Blood. 2003 Sep 15;102(6):2205-12. doi: 10.1182/blood-2002-09-2763. Epub 2003 May 15.
Blood. 2003.
PMID: 12750153
Free article.
Clinical Trial.